Axonal Transport Defects in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Molecular Neurobiology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s12035-014-8810-xPMID 25052480
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Presenilin influences glycogen synthase kinase-3 β (GSK-3β) for kinesin-1 and dynein function during axonal transport.

  2014cited by this paper
• The Role of SORL1 in Alzheimer’s Disease

  2014cited by this paper
• arly-onset cognitive deficits and axonal transport dysfunction in 301 S mutant tau transgenic mice

  2014cited by this paper
• Oxidative stress in Alzheimer’s disease

  2014cited by this paper
• Apolipoprotein E in Alzheimer's disease: an update.

  2014cited by this paper
• March separate, strike together--role of phosphorylated TAU in mitochondrial dysfunction in Alzheimer's disease.

  2014cited by this paper
• Proteasome inhibition induces stress kinase dependent transport deficits--implications for Alzheimer's disease.

  2014cited by this paper
• The Role of Cholesterol Metabolism in Alzheimer’s Disease

  2014cited by this paper
• Presenilin controls kinesin-1 and dynein function during APP-vesicle transport in vivo.

  2013cited by this paper
• Cyclophilin D Deficiency Rescues Axonal Mitochondrial Transport in Alzheimer’s Neurons

  2013cited by this paper
• Nebula/DSCR1 Upregulation Delays Neurodegeneration and Protects against APP-Induced Axonal Transport Defects by Restoring Calcineurin and GSK-3β Signaling

  2013cited by this paper
• Epigenetic mechanisms in Alzheimer's disease: implications for pathogenesis and therapy.

  2013cited by this paper
• Mitochondrial abnormalities in a streptozotocin-induced rat model of sporadic Alzheimer's disease.

  2013cited by this paper
• Mitochondrial dysfunction and calcium deregulation by the RanBP9‐cofilin pathway

  2013cited by this paper
• Loss of c-Jun N-terminal kinase-interacting protein-1 does not affect axonal transport of the amyloid precursor protein or Aβ production

  2013cited by this paper
• Global Axonal Transport Rates are Unaltered in Htau Mice in vivo

  2013cited by this paper
• Notch signalling in adult neurons: a potential target for microtubule stabilization

  2013cited by this paper
• NAP (davunetide) rescues neuronal dysfunction in a Drosophila model of tauopathy

  2013cited by this paper
• Endogenous GSK‐3/Shaggy Regulates Bidirectional Axonal Transport of the Amyloid Precursor Protein

  2013cited by this paper
• Calsyntenin-1 mediates axonal transport of the amyloid precursor protein and regulates Aβ production

  2012cited by this paper
• Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies.

  2012cited by this paper
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Reduced Axonal Transport and Increased Excitotoxic Retinal Ganglion Cell Degeneration in Mice Transgenic for Human Mutant P301S Tau

  2012cited by this paper
• Enhanced β-secretase processing alters APP axonal transport and leads to axonal defects.

  2012cited by this paper
• HDAC6 Inhibitor Blocks Amyloid Beta-Induced Impairment of Mitochondrial Transport in Hippocampal Neurons

  2012cited by this paper
• Loss of Axonal Mitochondria Promotes Tau-Mediated Neurodegeneration and Alzheimer's Disease–Related Tau Phosphorylation Via PAR-1

  2012cited by this paper
• Pathogenic Forms of Tau Inhibit Kinesin-Dependent Axonal Transport through a Mechanism Involving Activation of Axonal Phosphotransferases

  2011influential reference
• Tau inclusions in retinal ganglion cells of human P301S tau transgenic mice: effects on axonal viability.

  2011cited by this paper
• BACE1 Elevation is Involved in Amyloid Plaque Development in the Triple Transgenic Model of Alzheimer’s Disease: Differential Aβ Antibody Labeling of Early-Onset Axon Terminal Pathology

  2011cited by this paper
• Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.

  2011cited by this paper
• Quantification of myelin loss in frontal lobe white matter in vascular dementia, Alzheimer’s disease, and dementia with Lewy bodies

  2010cited by this paper
• Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport

  2010cited by this paper
• Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.

  2010cited by this paper
• Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model

  2010cited by this paper
• Aβ promotes Alzheimer’s disease‐like cytoskeleton abnormalities with consequences to APP processing in neurons

  2010cited by this paper
• Mitofusin 2 Is Necessary for Transport of Axonal Mitochondria and Interacts with the Miro/Milton Complex

  2010cited by this paper
• Amyloid-β Peptide Oligomers Disrupt Axonal Transport through an NMDA Receptor-Dependent Mechanism That Is Mediated by Glycogen Synthase Kinase 3β in Primary Cultured Hippocampal Neurons

  2010cited by this paper
• Aβ Oligomers Cause Localized Ca2+ Elevation, Missorting of Endogenous Tau into Dendrites, Tau Phosphorylation, and Destruction of Microtubules and Spines

  2010cited by this paper
• Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila

  2010cited by this paper
• Loss of tau elicits axonal degeneration in a mouse model of Alzheimer's disease.

  2010cited by this paper
• Mitochondrial Superoxide Contributes to Blood Flow and Axonal Transport Deficits in the Tg2576 Mouse Model of Alzheimer's Disease

  2010cited by this paper
• Regulation of axonal trafficking of cytochrome c oxidase IV mRNA.

  2010cited by this paper
• Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.

  2010cited by this paper
• The Mitochondrial Secret(ase) of Alzheimer's Disease

  2010cited by this paper
• Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease.

  2010cited by this paper
• Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

  2009cited by this paper
• Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta

  2009influential reference
• Pathogenic Huntingtin Inhibits Fast Axonal Transport by Activating JNK3 and Phosphorylating Kinesin

  2009cited by this paper
• Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease*

  2009cited by this paper
• The amino terminus of tau inhibits kinesin‐dependent axonal transport: Implications for filament toxicity

  2009influential reference
• Histone deacetylase 6 interacts with the microtubule‐associated protein tau

  2008influential reference
• Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease

  2008cited by this paper
• Aup1p, a Yeast Mitochondrial Protein Phosphatase Homolog, Is Required for Efficient Stationary Phase Mitophagy and Cell Survival*

  2007cited by this paper
• Impairments in Fast Axonal Transport and Motor Neuron Deficits in Transgenic Mice Expressing Familial Alzheimer's Disease-Linked Mutant Presenilin 1

  2007influential reference
• The novel cargo Alcadein induces vesicle association of kinesin‐1 motor components and activates axonal transport

  2007cited by this paper
• In vivo axonal transport rates decrease in a mouse model of Alzheimer's disease

  2007cited by this paper
• Interaction of tau protein with the dynactin complex

  2007cited by this paper
• Autophagy, amyloidogenesis and Alzheimer disease

  2007cited by this paper
• Tau binding to microtubules does not directly affect microtubule‐based vesicle motility

  2007influential reference
• PAT1a Modulates Intracellular Transport and Processing of Amyloid Precursor Protein (APP), APLP1, and APLP2*

  2006cited by this paper
• Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction

  2006cited by this paper
• Unloading kinesin transported cargoes from the tubulin track via the inflammatory c‐Jun N‐terminal kinase pathway

  2006cited by this paper
• Acute effect of β amyloid on synchronized spontaneous Ca2+ oscillations in cultured hippocampal networks

  2006cited by this paper
• Acute Impairment of Mitochondrial Trafficking by β-Amyloid Peptides in Hippocampal Neurons

  2006cited by this paper
• Axonopathy in an APP/PS1 transgenic mouse model of Alzheimer’s disease

  2006cited by this paper
• Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

  2006cited by this paper
• Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

  2006cited by this paper
• Oxidative stress in Alzheimer's disease.

  2006cited by this paper
• A peptide zipcode sufficient for anterograde transport within amyloid precursor protein

  2006cited by this paper
• JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport

  2006cited by this paper
• Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

  2005cited by this paper
• Coordinated transport of phosphorylated amyloid-β precursor protein and c-Jun NH2-terminal kinase–interacting protein-1

  2005cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

  2005cited by this paper
• Axonal Transport, Amyloid Precursor Protein, Kinesin-1, and the Processing Apparatus: Revisited

  2005cited by this paper
• Axonal Degeneration Induced by Targeted Expression of Mutant Human Tau in Oligodendrocytes of Transgenic Mice That Model Glial Tauopathies

  2005cited by this paper
• A novel CDK5‐dependent pathway for regulating GSK3 activity and kinesin‐driven motility in neurons

  2004cited by this paper
• Control of mitochondrial motility and distribution by the calcium signal

  2004cited by this paper
• Erratum: GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila (Molecular Psychiatry (2004) 9 (522-530) DOI:10.1038/sj.mp.4001483)

  2004cited by this paper
• GSK-3β inhibition reverses axonal transport defects and behavioural phenotypes in Drosophila

  2004cited by this paper
• Retarded Axonal Transport of R406W Mutant Tau in Transgenic Mice with a Neurodegenerative Tauopathy

  2004cited by this paper
• Glutamate and Amyloid β-Protein Rapidly Inhibit Fast Axonal Transport in Cultured Rat Hippocampal Neurons by Different Mechanisms

  2003cited by this paper
• Alzheimer's Presenilin 1 Mutations Impair Kinesin-Based Axonal Transport

  2003cited by this paper
• Single‐molecule investigation of the interference between kinesin, tau and MAP2c

  2002cited by this paper
• Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin‐based motility

  2002influential reference
• Coexpression of GSK-3 b Corrects Phenotypic Aberrations of Dorsal Root Ganglion Cells , Cultured from Adult Transgenic Mice Overexpressing Human Protein tau

  2002cited by this paper
• The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors.

  2001cited by this paper
• Cargo of Kinesin Identified as Jip Scaffolding Proteins and Associated Signaling Molecules

  2001cited by this paper
• Kinesin-mediated axonal transport of a membrane compartment containing β-secretase and presenilin-1 requires APP

  2001cited by this paper
• Regulation of Kinesin: Implications for Neuronal Development

  2001influential reference
• Axonal transport of amyloid precursor protein is mediated by direct binding to the kinesin light chain subunit of kinesin-I.

  2000cited by this paper
• Oxidative stress in Alzheimer's disease.

  2000cited by this paper
• GSK3 beta forms a tetrameric complex with endogenous PS1-CTF/NTF and beta-catenin. Effects of the D257/D385A and FAD-linked mutations.

  2000cited by this paper
• GSK3β Forms a Tetrameric Complex with Endogenous PS1‐CTF/NTF and β‐Catenin: Effects of the D257/D385A and FAD‐linked Mutations

  2000cited by this paper
• Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform.

  1999cited by this paper
• Mutations in tau reduce its microtubule binding properties in intact cells and affect its phosphorylation

  1999cited by this paper
• A Role for Cyclin-Dependent Kinase(s) in the Modulation of Fast Anterograde Axonal Transport: Effects Defined by Olomoucine and the APC Tumor Suppressor Protein

  1998cited by this paper
• Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau.

  1998cited by this paper
• Insulin activates protein kinase B, inhibits glycogen synthase kinase‐3 and activates glycogen synthase by rapamycin‐insensitive pathways in skeletal muscle and adipose tissue

  1997cited by this paper
• Wingless inactivates glycogen synthase kinase‐3 via an intracellular signalling pathway which involves a protein kinase C.

  1996cited by this paper

• Landscape of Protein Post-Translational Modifications in Age-Related Neurodegenerative Disorders: Implications in Protein Aggregation, Altered Cellular Processes, and Therapeutics.

  2026cites this paper
• Proteomics reveals three molecular subtypes of Alzheimer's disease with distinct progression patterns

  2026cites this paper
• The Alzheimer’s-Associated SORL1 p.Y1816C Variant Impairs APP Sorting, Axonal Trafficking, and Neuronal Activity in iPSC-Derived Brain Models

  2025cites this paper
• Tau protein structure and dynamics.

  2025cites this paper
• Potential common pathogenesis of several neurodegenerative diseases

  2025cites this paper
• Molecular mechanisms regulating PDE11A4 age-related liquid-liquid phase separation (LLPS) and its reversal by selective, potent and orally-available PDE11A4 small molecule inhibitors both in vitro and in vivo

  2025cites this paper
• The genetic landscape of early‐onset Alzheimer's disease in China

  2025cites this paper
• Immunoassay detection of multiphosphorylated tau proteoforms as cerebrospinal fluid and plasma Alzheimer’s disease biomarkers

  2025cites this paper
• How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies

  2025cites this paper
• The impact of tau deletion on Huntington's disease: an in vivo perspective.

  2025cites this paper
• Swedish Alzheimer’s disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways

  2024cites this paper
• Mitochondrial dysfunction and Alzheimer’s disease: pathogenesis of mitochondrial transfer

  2024cites this paper
• Rab11 suppresses neuronal stress signaling by localizing dual leucine zipper kinase to axon terminals for protein turnover

  2024cites this paper
• Proteomic insights into early-stage Alzheimer's disease: Identifying key neuronal proteins impacted by amyloid beta oligomers in an in vitro model.

  2024cites this paper
• Multiple Transcriptomic Analyses Explore Potential Synaptic Biomarker Rabphilin-3A for Alzheimer's Disease

  2024cites this paper
• Mitochondrial plasticity and synaptic plasticity crosstalk; in health and Alzheimer's disease

  2024cites this paper
• White matter alterations and their associations with biomarkers and behavior in subjective cognitive decline individuals: a fixel-based analysis

  2024cites this paper
• Prolonged depletion of profilin 1 or F-actin causes an adaptive response in microtubules

  2024cites this paper
• Unraveling the genetic architecture of blood unfolded p-53 among non-demented elderlies: novel candidate genes for early Alzheimer's disease

  2024cites this paper
• Novel avenues of tau research

  2024cites this paper
• Site-specific phosphorylation of tau impacts mitochondrial biology and response to stressors

  2023cites this paper
• How do neurons age? A focused review on the aging of the microtubular cytoskeleton

  2023cites this paper
• Calcium-Dependent Interaction of Nitric Oxide Synthase with Cytochrome c Oxidase: Implications for Brain Bioenergetics

  2023cites this paper
• Axon-Autonomous Effects of the Amyloid Precursor Protein Intracellular Domain (AICD) on Kinase Signaling and Fast Axonal Transport

  2023cites this paper
• Site‐specific phosphorylation of tau impacts mitochondrial function and response to stressors

  2023cites this paper
• Cytoskeletal adaptation following long-term dysregulation of actomyosin in neuronal processes

  2023cites this paper
• Control of microtubules in neuronal processes by profilin 1 and actomyosin

  2023cites this paper
• Targeting multiphosphorylated tau: technical and clinical validation of a new Simoa(R) assay for CSF and plasma detection of tau simultaneously phosphorylated at T181 and T231

  2023cites this paper
• Title: The axonal localization of Dual Leucine Zipper Kinase defines its protein-turnover

  2023influential citation
• Mechanisms associated with the dysregulation of mitochondrial function due to lead exposure and possible implications on the development of Alzheimer’s disease

  2022cites this paper
• The emerging role of autophagy and mitophagy in tauopathies: From pathogenesis to translational implications in Alzheimer’s disease

  2022cites this paper
• Development of a system to analyze oral frailty associated with Alzheimer's disease using a mouse model

  2022cites this paper
• Advances in Recapitulating Alzheimer’s Disease Phenotypes Using Human Induced Pluripotent Stem Cell-Based In Vitro Models

  2022cites this paper
• Long non-coding RNA MALAT1 protects against Aβ1-42 induced toxicity by regulating the expression of receptor tyrosine kinase EPHA2 via quenching miR-200a/26a/26b in Alzheimer's disease.

  2022cites this paper
• Recent Trends and Practices Toward Assessment and Rehabilitation of Neurodegenerative Disorders: Insights From Human Gait

  2022cites this paper
• In Vivo Imaging of Axonal Organelle Transport in the Mouse Brain.

  2022cites this paper
• Alzheimer Disease: Recent Updates on Apolipoprotein E and Gut Microbiome Mediation of Oxidative Stress, and Prospective Interventional Agents

  2022cites this paper
• p27, The Cell Cycle and Alzheimer´s Disease

  2022cites this paper
• Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis

  2021cites this paper
• A directional 3D neurite outgrowth model for studying motor axon biology and disease

  2021cites this paper
• Mitochondrial Behavior in Axon Degeneration and Regeneration

  2021cites this paper
• Simulation of a sudden drop-off in distal dense core vesicle concentration in Drosophila type II motoneuron terminals

  2021cites this paper
• Pathogenic MAPT mutations Q336H and Q336R have isoform‐dependent differences in aggregation propensity and microtubule dysfunction

  2021cites this paper
• Amyloid-β: A double agent in Alzheimer's disease?

  2021cites this paper
• The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type

  2021cites this paper
• Miro1 provides neuroprotection via the mitochondrial trafficking pathway in a rat model of traumatic brain injury.

  2021cites this paper
• Axonal transport dynamics explain directional bias in tau deposition

  2021cites this paper
• Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease

  2020cites this paper
• c-Jun N-Terminal Kinases in Alzheimer’s Disease: A Possible Target for the Modulation of the Earliest Alterations

  2020cites this paper
• Miro (Mitochondrial Rho GTPase), a key player of Mitochondrial axonal transport and Mitochondrial dynamics in Neurodegenerative diseases.

  2020cites this paper
• Potential Therapeutic Role of Phytochemicals to Mitigate Mitochondrial Dysfunctions in Alzheimer’s Disease

  2020cites this paper
• Amyloid-β, tau, and the cholinergic system in Alzheimer’s disease: seeking direction in a tangle of clues

  2020cites this paper
• Axonal Degeneration in AD: The Contribution of Aβ and Tau

  2020cites this paper
• Investigating the role of the insulin-like growth factor receptor (IGF1R) on axonal transport as a target for pharmacological intervention in Amyotrophic Lateral Sclerosis

  2019cites this paper
• The role of CD2AP in the Pathogenesis of Alzheimer's Disease

  2019cites this paper
• Sequential formation of different layers of dystrophic neurites in Alzheimer’s brains

  2019cites this paper
• A Role for Drosophila Amyloid Precursor Protein in Retrograde Trafficking of L1-Type Cell Adhesion Molecule Neuroglian

  2019cites this paper
• LMTK2 binds to kinesin light chains to mediate anterograde axonal transport of cdk5/p35 and LMTK2 levels are reduced in Alzheimer’s disease brains

  2019cites this paper
• Tau protein function: The mechanical exploration of axonal transport disorder caused by persistent pressure in dorsal root ganglia

  2019cites this paper
• Tau as a potential therapeutic target for ischemic stroke

  2019cites this paper
• Impaired tau–microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations

  2019cites this paper
• Altered mitochondrial dynamics in a novel cellular model of Leber Hereditary Optic Neuropathy (LHON)

  2018influential citation
• VGF nerve growth factor inducible is involved in retinal ganglion cells death induced by optic nerve crush

  2018cites this paper
• T‐complex protein 1‐ring complex enhances retrograde axonal transport by modulating tau phosphorylation

  2018cites this paper
• The Association of Tau With Mitochondrial Dysfunction in Alzheimer's Disease

  2018cites this paper
• Dyslipidemia impairs mitochondrial trafficking and function in sensory neurons

  2018cites this paper
• Microtubule self-healing and defect creation investigated by in-line force measurements during high-speed atomic force microscopy imaging.

  2018cites this paper
• Rôle de la dérégulation neuronale de la protéine kinase activée par l’AMP (AMPK) dans la pathologie tau, l’intégrité des synapses et le métabolisme énergétique : relevance pour la maladie d’Alzheimer

  2018cites this paper
• Early Candidate Urine Biomarkers for Detecting Alzheimer’s Disease Before Amyloid-β Plaque Deposition in an APP (swe)/PSEN1dE9 Transgenic Mouse Model

  2018cites this paper
• Focused design of polypharmacophoric neuroprotective compounds: Conjugates of γ-carbolines with carbazole derivatives and tetrahydrocarbazole

  2017cites this paper
• Linking deregulation of non-coding RNA to the core pathophysiology of Alzheimer's disease: An integrative review.

  2017cites this paper
• The Role Of Kinesin-2 In Navigating Microtubule Obstacles: Implications For The Regulation Of Axonal Transport

  2016cites this paper
• Single Differentiated Neurons from Pluripotent Embryonic Stem Cells: Motor Protein Modeling and Neurodegenerative Disease

  2016cites this paper
• MINI-SYMPOSIUM: ENERGY DEMAND AND ENERGY SUPPLY IN ALZHEIMER’S DISEASE Alzheimer’s Disease: From Mitochondrial Perturbations to Mitochondrial Medicine

  2016cites this paper
• Regulation of the kinesin-3 motor, KIF1A, in a cellular model of Alzheimer’s disease

  2016influential citation
• New Targets for Diagnosis and Treatment Against Alzheimer’s Disease: The Mitochondrial Approach

  2016cites this paper
• Mitochondrial traffic jams in Alzheimer's disease - pinpointing the roadblocks.

  2016cites this paper
• The Essential Role of Soluble Aβ Oligomers in Alzheimer’s Disease

  2016cites this paper
• The Role of MAPT in Neurodegenerative Diseases: Genetics, Mechanisms and Therapy

  2016cites this paper
• Acrylamide Retards the Slow Axonal Transport of Neurofilaments in Rat Cultured Dorsal Root Ganglia Neurons and the Corresponding Mechanisms

  2016cites this paper
• AMPK in Neurodegenerative Diseases.

  2016cites this paper
• MIRO GTPases in Mitochondrial Transport, Homeostasis and Pathology

  2015cites this paper
• Regulation of Microtubule Growth and Catastrophe: Unifying Theory and Experiment.

  2015cites this paper
• Mitochondrial Dysfunction Contributes to the Pathogenesis of Alzheimer's Disease

  2015cites this paper
• Anterograde transport blockade precedes deficits in retrograde transport in the visual projection of the DBA/2J mouse model of glaucoma

  2014cites this paper